Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.

@article{Duncan2005QualityOL,
  title={Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.},
  author={Graeme G. Duncan and JoelB. Epstein and Dongsheng Tu and Samy El Sayed and Andrea Bezjak and Jon A Ottaway and Joe Pater},
  journal={Head & neck},
  year={2005},
  volume={27 5},
  pages={
          421-8
        }
}
BACKGROUND The National Cancer Institute of Canada Clinical Trials Group undertook a multicenter, randomized, double-blind controlled trial of an oral antimicrobial versus placebo to prevent and treat mucositis. We present the quality of life (QOL) analysis for this trial. METHODS One hundred thirty-eight patients were randomly assigned. QOL data were collected every 2 weeks before, during, and after radiotherapy. The European Organization for Research and Treatment of Cancer Quality of Life… CONTINUE READING
BETA
Highly Cited
This paper has 71 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
SHOWING 1-10 OF 34 CITATIONS, ESTIMATED 48% COVERAGE

71 Citations

0510'07'10'13'16'19
Citations per Year
Semantic Scholar estimates that this publication has 71 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 51 REFERENCES

Similar Papers

Loading similar papers…